Neurobiological basis of chiropractic manipulative treatment of the spine in the care of major depression.


Journal

Acta bio-medica : Atenei Parmensis
ISSN: 2531-6745
Titre abrégé: Acta Biomed
Pays: Italy
ID NLM: 101295064

Informations de publication

Date de publication:
09 11 2020
Historique:
received: 25 08 2020
accepted: 17 09 2020
entrez: 10 11 2020
pubmed: 11 11 2020
medline: 29 6 2021
Statut: epublish

Résumé

Major depressive disorder is associated with an autonomic nervous system imbalance. All the symptoms of depression (high cortisol, high adrenalin, insomnia, agitation, anxiety) can probably be attributed to over-activation of the sympathetic nervous system. We performed this review in order to highlight the possible links between chiropractic intervention, its potential molecular effects and its possible outcomes on patients with depression. We performed a literature search for all the relevant manuscript regarding the effects of chiropractic and depression on the autonomic nervous system. Chiropractic care and spinal manipulation regulate the autonomic nervous system at peripheral level and its projections to the central nervous system. In particular, they may activate the parasympathetic system to counterbalance the activity of the sympathetic system. Vagal parasympathetic stimulation is also considered an effective therapy for major depression as it releases neurotrophins essential for anti-depressive therapies, including brain-derived neurotrophic factor and nerve growth factor. Chiropractic and spinal manipulative therapies along with vagal nerve stimulation may therefore be regarded as treatment options for depression.

Sections du résumé

BACKGROUND AND AIM
Major depressive disorder is associated with an autonomic nervous system imbalance. All the symptoms of depression (high cortisol, high adrenalin, insomnia, agitation, anxiety) can probably be attributed to over-activation of the sympathetic nervous system. We performed this review in order to highlight the possible links between chiropractic intervention, its potential molecular effects and its possible outcomes on patients with depression.
METHODS
We performed a literature search for all the relevant manuscript regarding the effects of chiropractic and depression on the autonomic nervous system.
RESULTS
Chiropractic care and spinal manipulation regulate the autonomic nervous system at peripheral level and its projections to the central nervous system. In particular, they may activate the parasympathetic system to counterbalance the activity of the sympathetic system. Vagal parasympathetic stimulation is also considered an effective therapy for major depression as it releases neurotrophins essential for anti-depressive therapies, including brain-derived neurotrophic factor and nerve growth factor.
CONCLUSION
Chiropractic and spinal manipulative therapies along with vagal nerve stimulation may therefore be regarded as treatment options for depression.

Identifiants

pubmed: 33170171
doi: 10.23750/abm.v91i13-S.10536
pmc: PMC8023121
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2020006

Références

Int J Neuropsychopharmacol. 2013 Mar;16(2):459-70
pubmed: 22717062
J Family Med Prim Care. 2018 May-Jun;7(3):629-631
pubmed: 30112321
Biol Psychol. 2007 Feb;74(2):200-11
pubmed: 17045728
Int J Neurosci. 2019 Mar;129(3):283-296
pubmed: 30235967
J Manipulative Physiol Ther. 2000 Feb;23(2):104-6
pubmed: 10714536
Brain Res. 2007 Nov 7;1179:28-34
pubmed: 17920573
Arch Gen Psychiatry. 1994 May;51(5):411-22
pubmed: 8179465
Neuropsychopharmacology. 2001 Nov;25(5):713-28
pubmed: 11682255
Curr Neurol Neurosci Rep. 2013 Aug;13(8):365
pubmed: 23780801
Drug Alcohol Depend. 2016 Feb 1;159:142-51
pubmed: 26790823
J Neurosci. 2008 Apr 9;28(15):4088-95
pubmed: 18400908
Exp Neurol. 2008 Dec;214(2):259-65
pubmed: 18804463
Int J Neuropsychopharmacol. 2007 Dec;10(6):817-26
pubmed: 17288644
Invest Radiol. 2001 Aug;36(8):470-9
pubmed: 11500598
Prog Neuropsychopharmacol Biol Psychiatry. 2017 Oct 3;79(Pt B):324-331
pubmed: 28710030
Acta Biomed. 2019 Sep 30;90(10-S):93-102
pubmed: 31577263
Science. 1984 Dec 14;226(4680):1342-4
pubmed: 6334362
Brain Stimul. 2013 Jan;6(1):78-83
pubmed: 22405742
Int J Neuropsychopharmacol. 2003 Sep;6(3):225-31
pubmed: 12974988
Biol Psychiatry. 2004 Apr 15;55(8):816-25
pubmed: 15050863
JAMA Psychiatry. 2016 Dec 1;73(12):1268-1275
pubmed: 27784035
Fundam Clin Pharmacol. 2015 Aug;29(4):394-403
pubmed: 25846646
Psychiatr Clin North Am. 2018 Sep;41(3):395-407
pubmed: 30098653
Sci Rep. 2018 Feb 7;8(1):2558
pubmed: 29416077
World J Biol Psychiatry. 2018 Aug;19(5):368-378
pubmed: 28281386
J Clin Psychiatry. 2005 Sep;66(9):1097-104
pubmed: 16187765
Clin Psychopharmacol Neurosci. 2014 Aug;12(2):83-93
pubmed: 25191499
Neural Plast. 2015;2015:581976
pubmed: 25878903
J Psychosom Res. 2006 Oct;61(4):447-51
pubmed: 17011351
Psychiatry Res. 2011 Mar 31;191(3):153-9
pubmed: 21306877
Neuropsychiatr Dis Treat. 2015 Apr 01;11:925-33
pubmed: 25897228
J Psychiatry Neurosci. 2009 Jul;34(4):272-80
pubmed: 19568478
Neurosci Biobehav Rev. 2004 Oct;28(6):547-63
pubmed: 15527862
Neuropsychopharmacology. 2012 Jul;37(8):1934-44
pubmed: 22491352
J Affect Disord. 2016 May;195:172-9
pubmed: 26896810
N Engl J Med. 1991 Aug 29;325(9):618-24
pubmed: 1861695
Brain Stimul. 2013 Sep;6(5):788-97
pubmed: 23485649
Neurotherapeutics. 2017 Jul;14(3):716-727
pubmed: 28585221
J Chiropr Med. 2008 Sep;7(3):86-93
pubmed: 19646369
Am J Epidemiol. 2011 Jun 15;173(12):1453-62
pubmed: 21527512

Auteurs

Aysha Karim Kiani (AK)

MAGI EUREGIO, Bolzano, Italy. ayshakiani@gmail.com.

Paolo Enrico Maltese (PE)

MAGI'S LAB, Rovereto (TN), Italy. paolo.maltese@assomagi.org.

Astrit Dautaj (A)

EBTNA-LAB, Rovereto (TN), Italy. astrit.dautaj@assomagi.org.

Stefano Paolacci (S)

MAGI'S LAB. stefano.paolacci@assomagi.org.

Danjela Kurti (D)

EBTNA-LAB, Rovereto (TN), Italy. danjela.kurti@hotmail.com.

Pietro Maria Picotti (PM)

Studio riabilitazione, Verona, Italy. info@picottiriabilita.eu.

Matteo Bertelli (M)

MAGI EUREGIO, Bolzano, Italy; MAGI'S LAB, Rovereto (TN), Italy; EBTNA-LAB, Rovereto (TN), Italy. matteo.bertelli@assomagi.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH